Global Human Coagulation Factor VIII Market Growth 2022-2028
As the global economy mends, the 2021 growth of Human Coagulation Factor VIII will have significant change from previous year. According to our latest study, the global Human Coagulation Factor VIII market size is USD million in 2022 from USD 10010 million in 2021, with a change of % between 2021 and 2022. The global Human Coagulation Factor VIII market size will reach USD 15590 million in 2028, growing at a CAGR of 6.5% over the analysis period.
The United States Human Coagulation Factor VIII market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Human Coagulation Factor VIII market, reaching US$ million by the year 2028. As for the Europe Human Coagulation Factor VIII landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Human Coagulation Factor VIII players cover Shire (Baxter), Bayer, CSL, and Pfizer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Coagulation Factor VIII market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Recombinant Factor VIII
Plasma-derived Factor VIII
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hemophilia A
Spontanous / Trauma
Surgical
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Shire (Baxter)
Bayer
CSL
Pfizer
Grifols
Biogen
Octapharma
NovoNordisk
Greencross
Kedrion
BPL
Hualan Bio
RAAS
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Coagulation Factor VIII Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Human Coagulation Factor VIII by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Human Coagulation Factor VIII by Country/Region, 2017, 2022 & 2028
2.2 Human Coagulation Factor VIII Segment by Type
2.2.1 Recombinant Factor VIII
2.2.2 Plasma-derived Factor VIII
2.3 Human Coagulation Factor VIII Sales by Type
2.3.1 Global Human Coagulation Factor VIII Sales Market Share by Type (2017-2022)
2.3.2 Global Human Coagulation Factor VIII Revenue and Market Share by Type (2017-2022)
2.3.3 Global Human Coagulation Factor VIII Sale Price by Type (2017-2022)
2.4 Human Coagulation Factor VIII Segment by Application
2.4.1 Hemophilia A
2.4.2 Spontanous / Trauma
2.4.3 Surgical
2.4.4 Other
2.5 Human Coagulation Factor VIII Sales by Application
2.5.1 Global Human Coagulation Factor VIII Sale Market Share by Application (2017-2022)
2.5.2 Global Human Coagulation Factor VIII Revenue and Market Share by Application (2017-2022)
2.5.3 Global Human Coagulation Factor VIII Sale Price by Application (2017-2022)
3 Global Human Coagulation Factor VIII by Company
3.1 Global Human Coagulation Factor VIII Breakdown Data by Company
3.1.1 Global Human Coagulation Factor VIII Annual Sales by Company (2020-2022)
3.1.2 Global Human Coagulation Factor VIII Sales Market Share by Company (2020-2022)
3.2 Global Human Coagulation Factor VIII Annual Revenue by Company (2020-2022)
3.2.1 Global Human Coagulation Factor VIII Revenue by Company (2020-2022)
3.2.2 Global Human Coagulation Factor VIII Revenue Market Share by Company (2020-2022)
3.3 Global Human Coagulation Factor VIII Sale Price by Company
3.4 Key Manufacturers Human Coagulation Factor VIII Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Coagulation Factor VIII Product Location Distribution
3.4.2 Players Human Coagulation Factor VIII Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Human Coagulation Factor VIII by Geographic Region
4.1 World Historic Human Coagulation Factor VIII Market Size by Geographic Region (2017-2022)
4.1.1 Global Human Coagulation Factor VIII Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Human Coagulation Factor VIII Annual Revenue by Geographic Region
4.2 World Historic Human Coagulation Factor VIII Market Size by Country/Region (2017-2022)
4.2.1 Global Human Coagulation Factor VIII Annual Sales by Country/Region (2017-2022)
4.2.2 Global Human Coagulation Factor VIII Annual Revenue by Country/Region
4.3 Americas Human Coagulation Factor VIII Sales Growth
4.4 APAC Human Coagulation Factor VIII Sales Growth
4.5 Europe Human Coagulation Factor VIII Sales Growth
4.6 Middle East & Africa Human Coagulation Factor VIII Sales Growth
5 Americas
5.1 Americas Human Coagulation Factor VIII Sales by Country
5.1.1 Americas Human Coagulation Factor VIII Sales by Country (2017-2022)
5.1.2 Americas Human Coagulation Factor VIII Revenue by Country (2017-2022)
5.2 Americas Human Coagulation Factor VIII Sales by Type
5.3 Americas Human Coagulation Factor VIII Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Coagulation Factor VIII Sales by Region
6.1.1 APAC Human Coagulation Factor VIII Sales by Region (2017-2022)
6.1.2 APAC Human Coagulation Factor VIII Revenue by Region (2017-2022)
6.2 APAC Human Coagulation Factor VIII Sales by Type
6.3 APAC Human Coagulation Factor VIII Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Human Coagulation Factor VIII by Country
7.1.1 Europe Human Coagulation Factor VIII Sales by Country (2017-2022)
7.1.2 Europe Human Coagulation Factor VIII Revenue by Country (2017-2022)
7.2 Europe Human Coagulation Factor VIII Sales by Type
7.3 Europe Human Coagulation Factor VIII Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Human Coagulation Factor VIII by Country
8.1.1 Middle East & Africa Human Coagulation Factor VIII Sales by Country (2017-2022)
8.1.2 Middle East & Africa Human Coagulation Factor VIII Revenue by Country (2017-2022)
8.2 Middle East & Africa Human Coagulation Factor VIII Sales by Type
8.3 Middle East & Africa Human Coagulation Factor VIII Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Coagulation Factor VIII
10.3 Manufacturing Process Analysis of Human Coagulation Factor VIII
10.4 Industry Chain Structure of Human Coagulation Factor VIII
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Coagulation Factor VIII Distributors
11.3 Human Coagulation Factor VIII Customer
12 World Forecast Review for Human Coagulation Factor VIII by Geographic Region
12.1 Global Human Coagulation Factor VIII Market Size Forecast by Region
12.1.1 Global Human Coagulation Factor VIII Forecast by Region (2023-2028)
12.1.2 Global Human Coagulation Factor VIII Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Human Coagulation Factor VIII Forecast by Type
12.7 Global Human Coagulation Factor VIII Forecast by Application
13 Key Players Analysis
13.1 Shire (Baxter)
13.1.1 Shire (Baxter) Company Information
13.1.2 Shire (Baxter) Human Coagulation Factor VIII Product Offered
13.1.3 Shire (Baxter) Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Shire (Baxter) Main Business Overview
13.1.5 Shire (Baxter) Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Human Coagulation Factor VIII Product Offered
13.2.3 Bayer Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 CSL
13.3.1 CSL Company Information
13.3.2 CSL Human Coagulation Factor VIII Product Offered
13.3.3 CSL Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 CSL Main Business Overview
13.3.5 CSL Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Human Coagulation Factor VIII Product Offered
13.4.3 Pfizer Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Grifols
13.5.1 Grifols Company Information
13.5.2 Grifols Human Coagulation Factor VIII Product Offered
13.5.3 Grifols Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Grifols Main Business Overview
13.5.5 Grifols Latest Developments
13.6 Biogen
13.6.1 Biogen Company Information
13.6.2 Biogen Human Coagulation Factor VIII Product Offered
13.6.3 Biogen Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Biogen Main Business Overview
13.6.5 Biogen Latest Developments
13.7 Octapharma
13.7.1 Octapharma Company Information
13.7.2 Octapharma Human Coagulation Factor VIII Product Offered
13.7.3 Octapharma Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Octapharma Main Business Overview
13.7.5 Octapharma Latest Developments
13.8 NovoNordisk
13.8.1 NovoNordisk Company Information
13.8.2 NovoNordisk Human Coagulation Factor VIII Product Offered
13.8.3 NovoNordisk Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 NovoNordisk Main Business Overview
13.8.5 NovoNordisk Latest Developments
13.9 Greencross
13.9.1 Greencross Company Information
13.9.2 Greencross Human Coagulation Factor VIII Product Offered
13.9.3 Greencross Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Greencross Main Business Overview
13.9.5 Greencross Latest Developments
13.10 Kedrion
13.10.1 Kedrion Company Information
13.10.2 Kedrion Human Coagulation Factor VIII Product Offered
13.10.3 Kedrion Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Kedrion Main Business Overview
13.10.5 Kedrion Latest Developments
13.11 BPL
13.11.1 BPL Company Information
13.11.2 BPL Human Coagulation Factor VIII Product Offered
13.11.3 BPL Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 BPL Main Business Overview
13.11.5 BPL Latest Developments
13.12 Hualan Bio
13.12.1 Hualan Bio Company Information
13.12.2 Hualan Bio Human Coagulation Factor VIII Product Offered
13.12.3 Hualan Bio Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Hualan Bio Main Business Overview
13.12.5 Hualan Bio Latest Developments
13.13 RAAS
13.13.1 RAAS Company Information
13.13.2 RAAS Human Coagulation Factor VIII Product Offered
13.13.3 RAAS Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 RAAS Main Business Overview
13.13.5 RAAS Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Human Coagulation Factor VIII Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Human Coagulation Factor VIII Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Recombinant Factor VIII
Table 4. Major Players of Plasma-derived Factor VIII
Table 5. Global Human Coagulation Factor VIII Sales by Type (2017-2022) & (K Bottles)
Table 6. Global Human Coagulation Factor VIII Sales Market Share by Type (2017-2022)
Table 7. Global Human Coagulation Factor VIII Revenue by Type (2017-2022) & ($ million)
Table 8. Global Human Coagulation Factor VIII Revenue Market Share by Type (2017-2022)
Table 9. Global Human Coagulation Factor VIII Sale Price by Type (2017-2022) & (USD/Bottle)
Table 10. Global Human Coagulation Factor VIII Sales by Application (2017-2022) & (K Bottles)
Table 11. Global Human Coagulation Factor VIII Sales Market Share by Application (2017-2022)
Table 12. Global Human Coagulation Factor VIII Revenue by Application (2017-2022)
Table 13. Global Human Coagulation Factor VIII Revenue Market Share by Application (2017-2022)
Table 14. Global Human Coagulation Factor VIII Sale Price by Application (2017-2022) & (USD/Bottle)
Table 15. Global Human Coagulation Factor VIII Sales by Company (2020-2022) & (K Bottles)
Table 16. Global Human Coagulation Factor VIII Sales Market Share by Company (2020-2022)
Table 17. Global Human Coagulation Factor VIII Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Human Coagulation Factor VIII Revenue Market Share by Company (2020-2022)
Table 19. Global Human Coagulation Factor VIII Sale Price by Company (2020-2022) & (USD/Bottle)
Table 20. Key Manufacturers Human Coagulation Factor VIII Producing Area Distribution and Sales Area
Table 21. Players Human Coagulation Factor VIII Products Offered
Table 22. Human Coagulation Factor VIII Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Human Coagulation Factor VIII Sales by Geographic Region (2017-2022) & (K Bottles)
Table 26. Global Human Coagulation Factor VIII Sales Market Share Geographic Region (2017-2022)
Table 27. Global Human Coagulation Factor VIII Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Human Coagulation Factor VIII Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Human Coagulation Factor VIII Sales by Country/Region (2017-2022) & (K Bottles)
Table 30. Global Human Coagulation Factor VIII Sales Market Share by Country/Region (2017-2022)
Table 31. Global Human Coagulation Factor VIII Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Human Coagulation Factor VIII Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Human Coagulation Factor VIII Sales by Country (2017-2022) & (K Bottles)
Table 34. Americas Human Coagulation Factor VIII Sales Market Share by Country (2017-2022)
Table 35. Americas Human Coagulation Factor VIII Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Human Coagulation Factor VIII Revenue Market Share by Country (2017-2022)
Table 37. Americas Human Coagulation Factor VIII Sales by Type (2017-2022) & (K Bottles)
Table 38. Americas Human Coagulation Factor VIII Sales Market Share by Type (2017-2022)
Table 39. Americas Human Coagulation Factor VIII Sales by Application (2017-2022) & (K Bottles)
Table 40. Americas Human Coagulation Factor VIII Sales Market Share by Application (2017-2022)
Table 41. APAC Human Coagulation Factor VIII Sales by Region (2017-2022) & (K Bottles)
Table 42. APAC Human Coagulation Factor VIII Sales Market Share by Region (2017-2022)
Table 43. APAC Human Coagulation Factor VIII Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Human Coagulation Factor VIII Revenue Market Share by Region (2017-2022)
Table 45. APAC Human Coagulation Factor VIII Sales by Type (2017-2022) & (K Bottles)
Table 46. APAC Human Coagulation Factor VIII Sales Market Share by Type (2017-2022)
Table 47. APAC Human Coagulation Factor VIII Sales by Application (2017-2022) & (K Bottles)
Table 48. APAC Human Coagulation Factor VIII Sales Market Share by Application (2017-2022)
Table 49. Europe Human Coagulation Factor VIII Sales by Country (2017-2022) & (K Bottles)
Table 50. Europe Human Coagulation Factor VIII Sales Market Share by Country (2017-2022)
Table 51. Europe Human Coagulation Factor VIII Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Human Coagulation Factor VIII Revenue Market Share by Country (2017-2022)
Table 53. Europe Human Coagulation Factor VIII Sales by Type (2017-2022) & (K Bottles)
Table 54. Europe Human Coagulation Factor VIII Sales Market Share by Type (2017-2022)
Table 55. Europe Human Coagulation Factor VIII Sales by Application (2017-2022) & (K Bottles)
Table 56. Europe Human Coagulation Factor VIII Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Human Coagulation Factor VIII Sales by Country (2017-2022) & (K Bottles)
Table 58. Middle East & Africa Human Coagulation Factor VIII Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Human Coagulation Factor VIII Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Human Coagulation Factor VIII Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Human Coagulation Factor VIII Sales by Type (2017-2022) & (K Bottles)
Table 62. Middle East & Africa Human Coagulation Factor VIII Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Human Coagulation Factor VIII Sales by Application (2017-2022) & (K Bottles)
Table 64. Middle East & Africa Human Coagulation Factor VIII Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Human Coagulation Factor VIII
Table 66. Key Market Challenges & Risks of Human Coagulation Factor VIII
Table 67. Key Industry Trends of Human Coagulation Factor VIII
Table 68. Human Coagulation Factor VIII Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Human Coagulation Factor VIII Distributors List
Table 71. Human Coagulation Factor VIII Customer List
Table 72. Global Human Coagulation Factor VIII Sales Forecast by Region (2023-2028) & (K Bottles)
Table 73. Global Human Coagulation Factor VIII Sales Market Forecast by Region
Table 74. Global Human Coagulation Factor VIII Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Human Coagulation Factor VIII Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Human Coagulation Factor VIII Sales Forecast by Country (2023-2028) & (K Bottles)
Table 77. Americas Human Coagulation Factor VIII Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Human Coagulation Factor VIII Sales Forecast by Region (2023-2028) & (K Bottles)
Table 79. APAC Human Coagulation Factor VIII Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Human Coagulation Factor VIII Sales Forecast by Country (2023-2028) & (K Bottles)
Table 81. Europe Human Coagulation Factor VIII Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Human Coagulation Factor VIII Sales Forecast by Country (2023-2028) & (K Bottles)
Table 83. Middle East & Africa Human Coagulation Factor VIII Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Human Coagulation Factor VIII Sales Forecast by Type (2023-2028) & (K Bottles)
Table 85. Global Human Coagulation Factor VIII Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Human Coagulation Factor VIII Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Human Coagulation Factor VIII Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Human Coagulation Factor VIII Sales Forecast by Application (2023-2028) & (K Bottles)
Table 89. Global Human Coagulation Factor VIII Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Human Coagulation Factor VIII Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Human Coagulation Factor VIII Revenue Market Share Forecast by Application (2023-2028)
Table 92. Shire (Baxter) Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 93. Shire (Baxter) Human Coagulation Factor VIII Product Offered
Table 94. Shire (Baxter) Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2022)
Table 95. Shire (Baxter) Main Business
Table 96. Shire (Baxter) Latest Developments
Table 97. Bayer Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 98. Bayer Human Coagulation Factor VIII Product Offered
Table 99. Bayer Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2022)
Table 100. Bayer Main Business
Table 101. Bayer Latest Developments
Table 102. CSL Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 103. CSL Human Coagulation Factor VIII Product Offered
Table 104. CSL Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2022)
Table 105. CSL Main Business
Table 106. CSL Latest Developments
Table 107. Pfizer Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 108. Pfizer Human Coagulation Factor VIII Product Offered
Table 109. Pfizer Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2022)
Table 110. Pfizer Main Business
Table 111. Pfizer Latest Developments
Table 112. Grifols Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 113. Grifols Human Coagulation Factor VIII Product Offered
Table 114. Grifols Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2022)
Table 115. Grifols Main Business
Table 116. Grifols Latest Developments
Table 117. Biogen Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 118. Biogen Human Coagulation Factor VIII Product Offered
Table 119. Biogen Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2022)
Table 120. Biogen Main Business
Table 121. Biogen Latest Developments
Table 122. Octapharma Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 123. Octapharma Human Coagulation Factor VIII Product Offered
Table 124. Octapharma Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2022)
Table 125. Octapharma Main Business
Table 126. Octapharma Latest Developments
Table 127. NovoNordisk Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 128. NovoNordisk Human Coagulation Factor VIII Product Offered
Table 129. NovoNordisk Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2022)
Table 130. NovoNordisk Main Business
Table 131. NovoNordisk Latest Developments
Table 132. Greencross Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 133. Greencross Human Coagulation Factor VIII Product Offered
Table 134. Greencross Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2022)
Table 135. Greencross Main Business
Table 136. Greencross Latest Developments
Table 137. Kedrion Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 138. Kedrion Human Coagulation Factor VIII Product Offered
Table 139. Kedrion Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2022)
Table 140. Kedrion Main Business
Table 141. Kedrion Latest Developments
Table 142. BPL Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 143. BPL Human Coagulation Factor VIII Product Offered
Table 144. BPL Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2022)
Table 145. BPL Main Business
Table 146. BPL Latest Developments
Table 147. Hualan Bio Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 148. Hualan Bio Human Coagulation Factor VIII Product Offered
Table 149. Hualan Bio Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2022)
Table 150. Hualan Bio Main Business
Table 151. Hualan Bio Latest Developments
Table 152. RAAS Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 153. RAAS Human Coagulation Factor VIII Product Offered
Table 154. RAAS Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2022)
Table 155. RAAS Main Business
Table 156. RAAS Latest Developments
List of Figures
Figure 1. Picture of Human Coagulation Factor VIII
Figure 2. Human Coagulation Factor VIII Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Coagulation Factor VIII Sales Growth Rate 2017-2028 (K Bottles)
Figure 7. Global Human Coagulation Factor VIII Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Human Coagulation Factor VIII Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Recombinant Factor VIII
Figure 10. Product Picture of Plasma-derived Factor VIII
Figure 11. Global Human Coagulation Factor VIII Sales Market Share by Type in 2021
Figure 12. Global Human Coagulation Factor VIII Revenue Market Share by Type (2017-2022)
Figure 13. Human Coagulation Factor VIII Consumed in Hemophilia A
Figure 14. Global Human Coagulation Factor VIII Market: Hemophilia A (2017-2022) & (K Bottles)
Figure 15. Human Coagulation Factor VIII Consumed in Spontanous / Trauma
Figure 16. Global Human Coagulation Factor VIII Market: Spontanous / Trauma (2017-2022) & (K Bottles)
Figure 17. Human Coagulation Factor VIII Consumed in Surgical
Figure 18. Global Human Coagulation Factor VIII Market: Surgical (2017-2022) & (K Bottles)
Figure 19. Human Coagulation Factor VIII Consumed in Other
Figure 20. Global Human Coagulation Factor VIII Market: Other (2017-2022) & (K Bottles)
Figure 21. Global Human Coagulation Factor VIII Sales Market Share by Application (2017-2022)
Figure 22. Global Human Coagulation Factor VIII Revenue Market Share by Application in 2021
Figure 23. Human Coagulation Factor VIII Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Human Coagulation Factor VIII Revenue Market Share by Company in 2021
Figure 25. Global Human Coagulation Factor VIII Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Human Coagulation Factor VIII Revenue Market Share by Geographic Region in 2021
Figure 27. Global Human Coagulation Factor VIII Sales Market Share by Region (2017-2022)
Figure 28. Global Human Coagulation Factor VIII Revenue Market Share by Country/Region in 2021
Figure 29. Americas Human Coagulation Factor VIII Sales 2017-2022 (K Bottles)
Figure 30. Americas Human Coagulation Factor VIII Revenue 2017-2022 ($ Millions)
Figure 31. APAC Human Coagulation Factor VIII Sales 2017-2022 (K Bottles)
Figure 32. APAC Human Coagulation Factor VIII Revenue 2017-2022 ($ Millions)
Figure 33. Europe Human Coagulation Factor VIII Sales 2017-2022 (K Bottles)
Figure 34. Europe Human Coagulation Factor VIII Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Human Coagulation Factor VIII Sales 2017-2022 (K Bottles)
Figure 36. Middle East & Africa Human Coagulation Factor VIII Revenue 2017-2022 ($ Millions)
Figure 37. Americas Human Coagulation Factor VIII Sales Market Share by Country in 2021
Figure 38. Americas Human Coagulation Factor VIII Revenue Market Share by Country in 2021
Figure 39. United States Human Coagulation Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Human Coagulation Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Human Coagulation Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Human Coagulation Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Human Coagulation Factor VIII Sales Market Share by Region in 2021
Figure 44. APAC Human Coagulation Factor VIII Revenue Market Share by Regions in 2021
Figure 45. China Human Coagulation Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Human Coagulation Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Human Coagulation Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Human Coagulation Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Human Coagulation Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Human Coagulation Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Human Coagulation Factor VIII Sales Market Share by Country in 2021
Figure 52. Europe Human Coagulation Factor VIII Revenue Market Share by Country in 2021
Figure 53. Germany Human Coagulation Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Human Coagulation Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Human Coagulation Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Human Coagulation Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Human Coagulation Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Human Coagulation Factor VIII Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Human Coagulation Factor VIII Revenue Market Share by Country in 2021
Figure 60. Egypt Human Coagulation Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Human Coagulation Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Human Coagulation Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Human Coagulation Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Human Coagulation Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Human Coagulation Factor VIII in 2021
Figure 66. Manufacturing Process Analysis of Human Coagulation Factor VIII
Figure 67. Industry Chain Structure of Human Coagulation Factor VIII
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
